Edition:
United Kingdom

Merrimack Pharmaceuticals Inc (MACK.OQ)

MACK.OQ on NASDAQ Stock Exchange Global Market

6.55USD
16 Aug 2019
Change (% chg)

$-0.02 (-0.30%)
Prev Close
$6.57
Open
$6.63
Day's High
$6.63
Day's Low
$6.54
Volume
2,892
Avg. Vol
10,305
52-wk High
$7.50
52-wk Low
$3.35

About

Merrimack Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in designing novel treatments for cancer by targeting biomarker-defined cancers. Its clinical programs include MM-121 (seribantumab), MM-141 (istiratumab) and MM-310. MM-121 is a fully human monoclonal antibody that binds to the... (more)
No analyst recommendations are available for .

Overall

Beta: 2.17
Market Cap(Mil.): $85.44
Shares Outstanding(Mil.): 13.35
Dividend: 1.50
Yield (%): --

Financials

  MACK.OQ Industry Sector
P/E (TTM): -- 98.31 33.85
EPS (TTM): -3.37 -- --
ROI: -87.87 7.52 12.69
ROE: -87.97 7.94 17.13
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates